Incremental treatment costs in national cancer institute-sponsored clinical trials.
about
Possible health benefits from reducing occupational magnetic fieldsTranslating research into practice: the role of provider-based research networks in the diffusion of an evidence-based colon cancer treatment innovation.The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies.Cost of cancer clinical trials in elderly patients.Patient income level and cancer clinical trial participation.Financial Burden of Cancer Clinical Trial Participation and the Impact of a Cancer Care Equity ProgramIncremental costs of prostate cancer trials: Are clinical trials really a burden on a public payer system?Responsibility for costs associated with clinical trialsAmerican Society of Clinical Oncology policy statement on medicaid reform.The impact of insurance on access to cancer clinical trials at a comprehensive cancer centerThe changing face of phase 1 cancer clinical trials: new challenges in study requirements.Treatment costs associated with interventional cancer clinical trials conducted at a single UK institution over 2 years (2009-2010)Insurance denials for cancer clinical trial participation after the Affordable Care Act mandate.Gemcitabine/dexamethasone/cisplatin vs cytarabine/dexamethasone/cisplatin for relapsed or refractory aggressive-histology lymphoma: cost-utility analysis of NCIC CTG LY.12.Recognizing the Financial Burden of Cancer Patients in Clinical Trials.The impact of health insurance mandates on drug innovation: evidence from the United States.Insurance Clearance for Early-Phase Oncology Clinical Trials Following the Affordable Care Act.Research Costs Investigated: A Study Into the Budgets of Dutch Publicly Funded Drug-Related Research.Incremental drug treatment cost in HIV-positive patients in industry-sponsored clinical trials.Clinical trial insurance coverage for cancer patients under the Affordable Care Act.
P2860
Q23915410-E79BB9EE-2B23-432C-825E-87D2C98C6A5AQ30417975-09A7D5A9-1849-4528-8AE0-B413041A0FF2Q33865329-AA22B05E-FADD-4910-8D4D-6BA1B3B95971Q35688141-808E901D-D645-45FF-9DC3-16E1E8CF2FA4Q36589626-858393E9-9745-4881-834D-E6342D8235AAQ36788307-0EFC121F-A383-406F-86F0-6BBC12B86B91Q36833759-4D89B068-66A5-4483-929D-643FF7EAE74DQ36925190-A28B5EC4-7E88-4252-8D98-25A6AAFAC2C5Q36934359-B7C5C1B7-4C1D-4653-8F28-ABA0319C32EBQ37023806-59E43239-176D-4137-9BF6-EDD3A25F1083Q37157732-E9DD2396-0023-44B7-A796-1F623103FCEEQ37235498-A3DC1EBF-8B9F-4BDE-8BF4-A66C0ABE42F4Q38740914-D395816D-B238-4A01-B1FB-EE42229237D2Q41080351-2B5E5AE3-B3CB-4FB2-BC49-E760F9AE2B92Q43248963-69E0FB59-ADFE-4F37-9B90-BACB2A800B1CQ43537931-F168A2D1-6AB4-48F1-B735-A77C80C868CCQ46662603-4EC1F39D-FEBE-4DCB-A1AC-F01C83726725Q47192296-B396463A-2422-4A5A-AA2B-33545D6578AEQ50121983-ED55B7C9-2030-4FAC-9442-1F2EDF81C62EQ55002577-13E2FB0C-47D9-4E2A-BB87-29CC07EAE3A2
P2860
Incremental treatment costs in national cancer institute-sponsored clinical trials.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Incremental treatment costs in national cancer institute-sponsored clinical trials.
@en
Incremental treatment costs in national cancer institute-sponsored clinical trials.
@nl
type
label
Incremental treatment costs in national cancer institute-sponsored clinical trials.
@en
Incremental treatment costs in national cancer institute-sponsored clinical trials.
@nl
prefLabel
Incremental treatment costs in national cancer institute-sponsored clinical trials.
@en
Incremental treatment costs in national cancer institute-sponsored clinical trials.
@nl
P2093
P356
P1476
Incremental treatment costs in national cancer institute-sponsored clinical trials.
@en
P2093
Arnold L Potosky
Dana P Goldman
Jane C Weeks
Jose J Escarce
Mary S McCabe
Matthias Schonlau
Meredith L Kilgore
Michael L Schoenbaum
Richard Kaplan
Sandra H Berry
P304
P356
10.1001/JAMA.289.22.2970
P407
P577
2003-06-01T00:00:00Z